Is it reasonable to add preoperative serum level of CEA and CA19-9 to staging for colorectal cancer?

Patients with an elevated level of both CEA and CA19-9 in stage II of colorectal cancer have a significantly poorer prognosis than those with normal levels of these markers. We recommend adding both CEA and CA19-9 to the current staging system.